Immunophenotype of pediatric-onset mastocytosis does not correlate with clinical course.
Shoshana GreenbergerHagai LandovYitzhak ConfinoHananya VaknineCamila AviviSharon BaumAviv BarzilaiPublished in: Pediatric dermatology (2019)
Our results confirm that CD30 is a sensitive marker for pediatric-onset mastocytosis. Nevertheless, its expression does not correlate with clinical subtype or clinical course. The sensitivity of CD25 is higher than that of CD2 in skin lesions.